Barinthus shareholders approve Scheme of Arrangement with 99.98% support

Barinthus Biotherapeutics plc.

Court Meeting: 99.98% by value of Scheme Shares voted for the Scheme of Arrangement (24,709,337 for, 3,772 against).
General Meeting: 99.98% of votes cast approved the Scheme Implementation Proposal (24,710,187 for, 3,922 against, 10 abstentions).
Both meetings held May 20, 2026; total Scheme Shares entitled to vote: 40,848,893.
All matters submitted were approved; results are final.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Barinthus Biotherapeutics plc. shareholders approved Approve the Scheme of Arrangement at the 2026-05-20 meeting.

Outcome: passed
Meeting: 2026-05-20

Exact text from the filing

1. To approve the Scheme Proposal. 24,709,337 3,772 0 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Barinthus Biotherapeutics plc. shareholders approved Approve the Scheme Implementation Proposal at the 2026-05-20 meeting.

Outcome: passed
Meeting: 2026-05-20

Exact text from the filing

1. To approve the Scheme Implementation Proposal. 24,710,187 3,922 10 0

View on SEC.gov

Browse all shareholder votes →

Barinthus Biotherapeutics plc. filing history →

Source: SEC EDGAR

accession 0001104659-26-064761

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.